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TO THE EDITOR
Cell fate is regulated by the activation
and repression of specific genes
(Sonkoly et al., 2007), and microRNAs
(miRNAs) are a class of posttranslational
regulators of gene expression.
Psoriasis is a hyperproliferative skin
disorder (Schneider, 2012) and it has
been reported that the stratified epider-
mis expresses miR135b (Joyce et al.,
2011), which suggests that miR135b is
closely related to epidermal keratini-
zation. Previously, we isolated three
populations of epidermal cells that
differed according to their ability to
adhere to type IV collagen (Kim et al.,
2004). Rapidly adhering (RA) cells, which
are considered to be epidermal stem
cells, express high levels of a6 integrin
and low levels of CD71. In contrast,
slowly adhering (SA) cells express low
levels of a6 integrin and high levels of
CD71 (Kim et al., 2004). Type IV
collagen-coated dishes were prepared
(CellmatrixType IV, Nitta Gelatin,
Osaka, Japan) and a subpopulation of
cells able to adhere within 10 minutes at
37 1C was selected (RA cells). Thereafter,
non-adherent cells were incubated for
another 24 hours, and, among them,
slowly adhering cells were selected (SA
cells). Total RNAs were prepared
and real-time reverse-transcriptase–PCR
(RT–PCR) analysis was performed.
Levels of miR135b were significantly
higher in SA cells (three different cell
lines from three volunteers, Supplemen-
tary Figure S1 online). To test the effects
of miR135b, cultured keratinocytes were
transfected with miR135b mimic (30 nM,
AM17100, PM13044, Ambion, Austin,
TX) or mock (as negative controls,
30 nM, AM17110, Ambion). Results
showed that miR135b mimic trans-
fected cells showed abnormal changes
compared with mock-transfected cells
(Supplementary Figure S2 online). These
findings suggested that miR135b initially
induced early differentiation of keratino-
cytes. Therefore, we suppressed miR135b
to clarify whether inhibition of miR135b
might target and delay differentiation
of keratinocytes. The transfection was
performed with an anti-miRNA inhibitor
(ib-miR135b, AM17000, AM13044,
Ambion) designed for hsa-miR135b or a
negative control (AM17010, Ambion) at
a final concentration of 30 nM according
to the manufacturer’s instruction. To
check transfection efficiency, an FAM-
labeled miRNA was transfected and the
results showed successful transfection
(Supplementary Figure S3 online). There-
after, the transfected FAM-labeled
miRNA was not observed at day 7 after
transfection (Supplementary Figure S3
online), which means that the transfected
miRNA persisted only for a few days. At
every passage, transfection was repeat-
edly performed, and portions of cells
were collected for cell counting, RNA
extraction, and protein extraction. RT–
PCR analysis showed that transfection of
ib-miR135b effectively suppresses
miR135b (Figure 1a). Cumulative cell
numbers showed a large difference
(Figure 1b). A colony assay showed that
ib-miR135b-transfected cells showed a
higher colony-forming ability than
mock-transfected cells (Supplementary
Figure S4 online). At the 9th passage,
ib-miR135b-transfected cells reached
B51010 cells (Figure 1b). However,
mock-transfected cells increased to only
1.61010 cells (Figure 1b). In addition,
mock-transfected cells showed large
vacuoles earlier than ib-miR135b-trans-
fected cells (Figure 1b, arrow). Large
vacuoles frequently appeared in the
cytoplasm, especially in late passages,
during the culture of keratinocytes (per-
sonal observation). However, these find-
ings are not described in detail in the
literature. The vacuolar alteration hasAccepted article preview online 15 October 2013; published online 14 November 2013
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H-R Choi et al.
Stratified Epidermis Expresses miR135b
www.jidonline.org 1161
been described as one type of degen-
eration of keratinocytes in the skin
(Yamamoto et al., 1995). Although
cultured cells are different from those
of in vivo skin, our observations suggest
that the inhibition of miR135b is
effective in preventing degenerative
changes of epidermal cells. We then
checked the levels of p63, a known
potential stem cell marker (Yang et al.,
1999). Our results showed that the
levels of p63 were consistently higher
in ib-miR135b-transfected cells than in
mock-transfected cells (Figure 1c).
These results correlate well with the
increased proliferative potential of ib-
miR135b-transfected cells.
To confirm the proliferative effects of
ib-miR135b, skin models were con-
structed using ib-miR135b- or mock-
transfected cells. Sections were stained
after 13 days. Although both models
showed a similar stratification of the
epidermis, the number of p63-positive
cells and proliferating cell nuclear
antigen-positive cells was higher in the
ib-miR135b model than in the mock
model (Figure 2a). These findings sug-
gested that the inhibition of miR135b
may prolong the stemness and prolif-
erative potential of epidermal keratino-
cytes. Subsequently, examination of the
niche environment of epidermal cells
showed that the expression of type IV
collagen increased in the ib-miR135b
model (Figure 2a). These findings sug-
gest that type IV collagen may be a
target of miR135b. Furthermore, the
levels of a6 integrin and b1 integrin
increased in the ib-miR135b model
(Figure 2a). In a monolayer culture,
expression of COL4A3 was increased
by the inhibition of miR135b (Supple-
mentary Figure S5 online) as shown in a
skin model study. We searched data-
bases to clarify whether type IV col-
lagen is a target of miR135b and found
that there is a binding site of hsa-
miR135b in the 30UTR region of the
COL4A3 gene (www.targetscan.com).
A protective sequence was designed to
inhibit binding of miR135b in the
30UTR region of COL4A3 gene (miS-
cript Target protector, Qiagen, Hilden,
Germany). When cells were transfected
with miR135b mimic, they became
larger (passages 3 and 4, Figures 2b–2).
Enlarged keratinocytes may be differ-
entiated cells. Furthermore, the protec-
tive sequence of miR135b abolished
these effects (Figures 2b–3). RT–PCR
analysis also showed that ‘‘miR135b
mimic’’ decreased the expression
levels of COL4A3, and the protective
sequence of miR135b reversed these
effects (Figure 2c). These findings sug-
gested that type IV collagen is a target
of miR135b and is important in main-
taining the proliferative potential of
keratinocytes. To clarify the prolifera-
tive effects, levels of EGF were investi-
gated by RT–PCR analysis. Results
showed that the expression of EGF
increased after ib-miR135b treatment
(Supplementary Figure S6 online). It
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Figure 1. Transfection of ib-miR135b increased the proliferative potential of keratinocytes. (a) Real-time reverse-transcriptase–PCR (RT–PCR) analysis of
transfected cells. Total RNAs were extracted, and the expression of microRNAs (miRNAs) was assayed using the TaqMan MicroRNA Assays (#4427975, 002261,
Applied Biosystems, Foster City, CA) specific for hsa-miR135b. cDNA was synthesized, and RT–PCR was conducted. (b) Long-term culture of transfected
keratinocytes. Large keratinocytes with numerous vacuoles appeared quicker in mock-transfected cells than with ib-miR135b-transfected cells. This experiment
was repeated twice and representative data are shown. Arrows indicate large keratinocytes with vacuoles. Cell numbers were counted at every passage, and the
cumulative number is shown. (c) Transfection of ib-miR135b increased the levels of p63. Cells were collected from passages 4 to 7. Proteins were extracted, and
western blotting was performed. The ib-miR135b-transfected cells showed higher levels of p63 compared with mock-transfected cells. The experiment was
repeated twice, and representative data are shown. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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suggested that the increased expression
of EGF may be a mechanism by which
ib-miR135b-transfected cells increased
proliferation potential.
This study showed that type IV col-
lagen is a target of miR135b and that the
inhibition of miR135b may improve the
microenvironment and may increase
the proliferative potential of basal cells.
Our results showed the role of miR135b
in epidermal keratinocytes and may
provide a way to manipulate stem cell
fate in the skin.
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Figure 2. The inhibition of miR135b prolongs the stemness and proliferative potential of epidermal keratinocytes (KC) in skin equivalent (SE) models, and type IV
collagen is found to be a target of miR135b. (a) Histology of the SE and immunohistochemical staining for p63 (sc-8431, Santa Cruz Biotechnology, Santa Cruz,
CA), proliferating cell nuclear antigen (PCNA; #M0879, DAKO, Glostrup, Denmark), type IV collagen (239M-16, Cell Marque, Rocklin, CA), integrin b1 (sc-9970,
Santa Cruz Biotechnology), and integrin a6 (sc-6597, Santa Cruz Biotechnology). SEs were constructed with ib-mock-transfected or with ib-miR135b-transfected
keratinocytes. Expression levels of p63, PCNA, type IV collagen, integrin b1, and integrin a6 were increased in SEs constructed with ib-miR135b-transfected
cells. Image analysis results of immunohistochemical staining (below). (b) Fast-forward co-transfection with ‘‘miRNA mimic’’ and ‘‘target protector’’ was
performed according to the manufacturer’s protocol (HiPerFect Tansfection Reagents, #301705, Qiagen). (b-1) Negative control of miRNA mimic (10 nM) and
negative control of target protector (500 nM, MTP0000002, Qiagen), (b-2) miRNA mimic (10nM) and negative control of target protector (500 nM), and (b-3)
miRNA mimic and target protector (500nM MTP0074146, Qiagen). Keratinocyte basal medium (KBM; 200ml), which contained corresponding sequences, was
added into six-well plates. Thereafter, cells (2105 cells in 1 ml of KGM) were seeded. After 2 days, medium was replaced with 2 ml of KGM. After another day,
cells were split and transfected. (c) Total RNA was isolated from cells with an Allprep Mini Kit (80004, Qiagen). An amount of 1mg total RNA was reverse
transcribed to cDNA using the ImProm-II Reverse Transcription System (A3800, Promega, Madison, WI) and Oligo(dT)15 Primer according to the manufacturer’s
instructions. Real-time PCR was performed with TaqMan Gene Expression Master Mix (#4369016, Applied Biosystems) and target gene primers, TaqMan Gene
Expression Assays for COL4A3 (#4331182, Applied Biosystems) on a 7500 Real-time PCR System. The housekeeping gene, glyceraldehyde-3-phosphate
dehydrogenase (#43352934E, Applied Biosystems), was used as an endogenous control. H&E, hematoxylin and eosin.
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Filaggrin Is a Predominant Member of the
Denaturation-Resistant Nickel-Binding Proteome of
Human Epidermis
Journal of Investigative Dermatology (2014) 134, 1164–1166; doi:10.1038/jid.2013.445; published online 21 November 2013
TO THE EDITOR
Excessive nickel skin exposure may
cause contact sensitization (Thyssen
and Menne´, 2010). There appears to
be a link between the expression of
the skin protein filaggrin and the pro-
pensity of becoming nickel sensitized.
Approximately 10% of Northern Euro-
peans carry at least one filaggrin null
mutation, which is associated with
ichthyosis vulgaris (Smith et al., 2006),
atopic dermatitis (Palmer et al., 2006),
and allergic nickel dermatitis (Novak
et al., 2007; Ross-Hansen et al., 2011).
Double-allele null mutations lead to a
complete lack of filaggrin. The protein is
expressed just below the outermost skin
layer, stratum corneum (SC), as a large
polyprotein, profilaggrin (Sandilands
et al., 2009). It consists of 10–12 equally
sized filaggrin units that vary by up
to 40% in amino-acid composition and
are released by enzymatic processing
(Thulin et al., 1996; Sandilands et al.,
2009). In the SC, filaggrin is degraded
to amino acids, which are major contri-
butors to water binding (Kezic et al.,
2008). Hence, filaggrin molecules cons-
titute a heterogeneous protein popu-
lation. As filaggrin is an abundant
histidine-rich protein (McKinley-Grant
et al., 1989), we hypothesized that it
contributes to epidermal nickel binding.
Consequently, lack of filaggrin could
cause increased percutaneous nickel
penetration and ultimately sensitization.
We investigated whether filaggrin from
human epidermal extracts bound nickel
and evaluated the binding potential of
other proteins. The full protein spectrum
from ex vivo epidermal samples was
visualized by SDS-PAGE (Figure 1,
lane 2). Immunoblotting with monoclo-
nal anti-filaggrin antibodies revealed the
size range of filaggrin molecules with
major reactivity at a molecular weight
corresponding to a heterogeneous mono-
mer population (Figure 1, lanes 8 and
10–12, arrowhead). Nondenaturing bind-
ing studies with column-packed nickel
Sepharose showed that filaggrin among
other proteins was enriched by
immobilized metal affinity chromatogra-
phy (IMAC) (Figure 1, lanes 4–6 and 10–
12). To verify the specificity of the anti-
bodies and identify other nickel-binding
proteins, the protein contents of lane 4
(Figure 1) were identified by systemati-
cally cutting out gel slices and analyzing
by tandem mass spectrometry (MS). This
analysis gave a semiquantitative measure
of the 20 most abundant nickel-binding
proteins (Supplementary Table S1 online).
Filaggrin was found in top 6, and most of
the other proteins were previously repor-
ted to bind nickel and/or other divalent
metals (Supplementary Table S1 online).
Whether the proteins were captured
on-column through protein interactions
rather than direct nickel binding was
studied by varying the washing stringency
conditions. Increasing salt concentration
(0.5–2 M NaCl) or urea gradient washing
(2–8 M urea) did not result in filaggrin
release, nor did it negate the binding of
the other identified proteins (data not
shown). Under denaturing and reducing
conditions, i.e., by washing the column
with 2% SDS and 0.1M DTT (Figure 2a),
most proteins including a low-molecular-
weight filaggrin species were released
(Figure 2a, lanes 6 and 14). The mono-
mers and larger filaggrin moleculesAccepted article preview online 24 October 2013; published online 21 November 2013
Abbreviations: DTT, dithiothreitol; IMAC, immobilized metal affinity chromatography; MS, mass
spectrometry; SC, stratum corneum
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